Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) - Net Assets

Latest as of June 2025: CN¥2.23 Billion CNY ≈ $325.86 Million USD

Based on the latest financial reports, Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has net assets worth CN¥2.23 Billion CNY (≈ $325.86 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.47 Billion ≈ $360.76 Million USD) and total liabilities (CN¥238.50 Million ≈ $34.90 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See Jiangsu Canopus Wisdom Medical Technolog balance sheet independence to measure how much of total assets are equity-financed.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥2.23 Billion
% of Total Assets 90.33%
Annual Growth Rate 22.94%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 41.91

Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A - Net Assets Trend (2020–2024)

This chart illustrates how Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Jiangsu Canopus Wisdom Medical Technolog stock valuation.

Annual Net Assets for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)

The table below shows the annual net assets of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A from 2020 to 2024. Also explore net asset momentum of Jiangsu Canopus Wisdom Medical Technolog to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2024-12-31 CN¥2.25 Billion
≈ $329.77 Million
+0.33%
2023-12-31 CN¥2.25 Billion
≈ $328.69 Million
+1.93%
2022-12-31 CN¥2.20 Billion
≈ $322.48 Million
+100.81%
2021-12-31 CN¥1.10 Billion
≈ $160.59 Million
+11.26%
2020-12-31 CN¥986.37 Million
≈ $144.34 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 164.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥430.62 Million 19.17%
Other Components CN¥1.82 Billion 80.83%
Total Equity CN¥2.25 Billion 100.00%

Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Competitors by Market Cap

The table below lists competitors of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A ranked by their market capitalization.

Company Market Cap
Shanghai Trendzone Decor Grp
SHG:603030
$400.83 Million
Unico Silver Ltd
AU:USL
$400.91 Million
Q2 METALS CORP.
F:458
$400.94 Million
Pacific Biosciences of California
NASDAQ:PACB
$400.97 Million
Wei Long Grape Wine Co Ltd
SHG:603779
$400.42 Million
Fujian Oriental Silver Star Investment Co Ltd
SHG:600753
$400.37 Million
Picpay Holdings Netherlands N.V. Class A Common Shares
NASDAQ:PICS
$400.30 Million
Zhejiang Dibay Electric Co Ltd
SHG:603320
$400.27 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,238,716,686 to 2,246,597,317, a change of 7,880,631 (0.4%).
  • Net income of 97,424,753 contributed positively to equity growth.
  • Dividend payments of 59,590,351 reduced retained earnings.
  • Other factors decreased equity by 29,953,771.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥97.42 Million +4.34%
Dividends Paid CN¥59.59 Million -2.65%
Other Changes CN¥-29.95 Million -1.33%
Total Change CN¥- 0.35%

Book Value vs Market Value Analysis

This analysis compares Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.22x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 2.10x to 1.22x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-12-31 CN¥12.99 CN¥27.33 x
2021-12-31 CN¥14.46 CN¥27.33 x
2022-12-31 CN¥21.87 CN¥27.33 x
2023-12-31 CN¥22.35 CN¥27.33 x
2024-12-31 CN¥22.43 CN¥27.33 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 4.34%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 22.37%
  • • Asset Turnover: 0.18x
  • • Equity Multiplier: 1.10x
  • Recent ROE (4.34%) is below the historical average (6.34%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 8.17% 21.29% 0.33x 1.17x CN¥-17.89 Million
2021 10.15% 24.69% 0.36x 1.15x CN¥1.64 Million
2022 4.68% 23.19% 0.19x 1.09x CN¥-116.62 Million
2023 4.34% 22.42% 0.18x 1.07x CN¥-126.65 Million
2024 4.34% 22.37% 0.18x 1.10x CN¥-127.23 Million

Industry Comparison

This section compares Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $1,931,992,553
  • Average return on equity (ROE) among peers: 10.97%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) CN¥2.23 Billion 8.17% 0.11x $400.62 Million
Shanghai Kehua Bio-Engineering Co Ltd (002022) $931.34 Million 24.19% 0.17x $422.24 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) $405.69 Million 15.24% 0.11x $3.84 Billion
Double Medical Technology Inc (002901) $3.69 Billion 16.27% 0.34x $2.35 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) $615.62 Million 6.75% 0.04x $520.92 Million
Lepu Medical Tech Beijing (300003) $5.34 Billion 9.76% 0.45x $3.09 Billion
INKON Life Technology Co Ltd (300143) $2.24 Billion 5.72% 0.18x $797.29 Million
Edan Instruments Inc (300206) $1.18 Billion 2.94% 0.08x $968.68 Million
Guangdong Biolight Meditech Co Ltd (300246) $354.32 Million 9.53% 0.12x $609.04 Million
Beijing Leadman Biochemistry Co Ltd (300289) $1.43 Billion 5.13% 0.23x $460.12 Million
Sinocare Inc (300298) $3.14 Billion 14.20% 0.47x $1.28 Billion

About Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A

SHE:301290 China Medical Devices
Market Cap
$400.62 Million
CN¥2.74 Billion CNY
Market Cap Rank
#13507 Global
#4041 in China
Share Price
CN¥27.33
Change (1 day)
+0.92%
52-Week Range
CN¥22.62 - CN¥35.89
All Time High
CN¥50.85
About

Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. engages in the research, development, manufacture, and sale of surgical medical devices and spare parts in China. It offers orthopedic traction frames, surgical lamps, hospital system integration solutions, electric gynecological examination tables, obstetrics and gynecology examination tables, electric operating tables, multi-functional intellig… Read more